Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.30 |
| ▸ | MGLL | Q99685 | 2/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31040895 | 1.00 | CYP1B1 (0.36) | CYP1B1PKMHTTSMN1; SMN2HSD17B10 | |
| SCHEMBL13096342 | 1.00 | CYP1B1 (0.36) | CYP1B1PKMHTTSMN1; SMN2HSD17B10 | |
| SCHEMBL15715894 | 1.00 | CYP1B1 (0.36) | CYP1B1PKMHTTSMN1; SMN2HSD17B10 | |
| SCHEMBL30482050 | 0.96 | CYP1B1 (0.39) | CYP1B1PKMHTTSMN1; SMN2HSD17B10 | |
| SCHEMBL25221349 | 0.96 | CYP1B1 (0.39) | CYP1B1PKMHTTSMN1; SMN2HSD17B10 | |
| SCHEMBL19821717 | 0.90 | ALDH1A1 (0.38) | CYP1B1 | |
| SCHEMBL30481775 | 0.86 | CYP1B1 (0.39) | CYP1B1HTTSMN1; SMN2LMNA | |
| SCHEMBL12217052 | 0.83 | CYP1B1 (0.38) | CYP1B1HTTSMN1; SMN2LMNA | |
| SCHEMBL12499359 | 0.83 | CYP1B1 (0.38) | CYP1B1HTTSMN1; SMN2LMNA | |
| SCHEMBL17146895 | 0.82 | CYP1B1 (0.37) | CYP1B1PKMHTTSMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250040332-A1 | VISIBLY TRANSPARENT, ULTRAVIOLET-ABSORBING PHOTOVOLTAIC DEVICES | UBIQUITOUS ENERGY, INC. (US) | 2025-01-30 | — | — | US | disclosed |
| US-20240298514-A1 | VISIBLY TRANSPARENT, NEAR-INFRARED-ABSORBING AND ULTRAVIOLET-ABSORBING PHOTOVOLTAIC DEVICES | UBIQUITOUS ENERGY, INC. (US) | 2024-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240298514-A1 | VISIBLY TRANSPARENT, NEAR-INFRARED-ABSORBING AND ULTRAVIOLET-ABSORBING PHOTOVOLTAIC DEVICES | CRY2, CRY1, ERCC1 | CYP1B1 2132/4885PKM 2216/4885HTT 447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.